The new antidepressants. Selective serotonin reuptake inhibitors

Pediatr Clin North Am. 1998 Oct;45(5):1137-55, ix. doi: 10.1016/s0031-3955(05)70066-3.

Abstract

This article provides a resource for choosing among available SSRIs to treat pediatric patients. SSRIs are addressed according to five areas of interest: treatment efficacy data, untoward effects profile, pharmacokinetic characteristics, potential drug-drug interactions, and cost. Strategies for SSRI dosing and pretreatment work-up are also discussed. Included in the article is a reference table for SSRI dosing, available preparations, and cost per dose. Also included is an abbreviated reference table of important cytochrome P-450 isoenzymes, isoenzyme inhibition by SSRIs, and selected psychotropic and somatic medication substrates.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Anxiety Disorders / drug therapy*
  • Child
  • Depressive Disorder / drug therapy*
  • Drug Costs
  • Drug Interactions
  • Humans
  • Selective Serotonin Reuptake Inhibitors / classification
  • Selective Serotonin Reuptake Inhibitors / economics
  • Selective Serotonin Reuptake Inhibitors / pharmacology
  • Selective Serotonin Reuptake Inhibitors / therapeutic use*

Substances

  • Serotonin Uptake Inhibitors